🔎 Trials Near Me

Utama › Leukemia Sel-B › Ohio

Kajian klinikal Leukemia Sel-B di Ohio

7 kajian untuk Leukemia Sel-B sedang mencari peserta di lokasi di Ohio.

Bandar di Ohio

Teks kajian rasmi (Bahasa Inggeris)

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

  • Research Site, Columbus
Mengambil pesertaFasa 4
Umur 18 hingga 130 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06651970

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

  • Research Site, Columbus
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06564038

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

  • Research Site, Cleveland
Mengambil pesertaFasa 3
Umur 18 hingga 18 · Semua jantina · Dikemas kini 8 Sep 2026 · NCT07509151

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Mengambil pesertaFasa 2
Umur 7 hingga 25 · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT05082519

ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

  • OSU Comprehensive Cancer Center, Columbus
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT07342478

A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies

  • University of Cincinnati, Cincinnati
  • The Ohio State University, Columbus
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06708897

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

  • Gabrail Cancer Center Research,, Canton
Mengambil pesertaFasa 1/2
Umur 12 hingga 95 · Semua jantina · Dikemas kini 15 Apr 2026 · NCT04329728

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.